A tuberculosis (TB) vaccine invented a century ago may offer a possible cure for type 1 diabetes, according to researchers in the US.
The scientists have published results from an early-stage trial which suggest that the 90-year-old vaccine bacillus Calmette-Guérin (BCG) can reverse type 1 diabetes by regenerating the insulin-producing beta cells in the pancreas.
Denise Faustma, director of the Massachusetts General Hospital Immunobiology Laboratory, found in previous research with mice that rising levels of a protein known as tumor necrosis factor (TNF) can destroy “bad” anti-insulin T-cells – a key factor in the development of type 1 diabetes – and restore beta cell function.
As the BCG vaccine has been shown to safely raise TNF levels, the researchers tested it on three patients with long-term type 1 diabetes.
After 20 weeks, they discovered an increase in dead “bad” T-cells, an increase in “good” regulatory T cells and a significant hike in C-peptide levels (a marker of pancreatic insulin secretion) in two of the three vaccine patients, which they said indicated a restoration of insulin production.
Faustman and her colleagues are now trying to raise $25 million to conduct larger human trials which, if successful, could lead to the BCG vaccine being used as a long-term solution to type 1 diabetes.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…